Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial.

PURPOSE To determine the long-term outcome and health-related quality of life (HRQL) of patients with endometrial carcinoma (EC) treated with or without pelvic radiotherapy in the Post Operative Radiation Therapy in Endometrial Carcinoma 1 (PORTEC-1) trial. PATIENTS AND METHODS Between 1990 and 1997, 714 patients with stage IC grade 1 to 2 or IB grade 2 to 3 EC were randomly allocated to pelvic external-beam radiotherapy (EBRT) or no additional treatment (NAT). HRQL was evaluated with the Short Form 36-Item (SF-36) questionnaire; subscales from the European Organisation for Research and Treatment of Cancer (EORTC) PR25 module for bowel and bladder symptoms and the OV28 and CX24 modules for sexual symptoms; and demographic questions. Analysis was by intention-to-treat. RESULTS Median follow-up was 13.3 years. The 15-year actuarial locoregional recurrence rates were 5.8% for EBRT versus 15.5% for NAT (P < .001), and 15-year overall survival was 52% versus 60% (P = .14). Of the 351 patients confirmed to be alive with correct address, 246 (70%) returned the questionnaire. Patients treated with EBRT reported significant (P < .01) and clinically relevant higher rates of urinary incontinence, diarrhea, and fecal leakage leading to more limitations in daily activities. Increased symptoms were reflected by the frequent use of incontinence materials after EBRT (day and night use, 42.9% v 15.2% for NAT; P < .001). Patients treated with EBRT reported lower scores on the SF-36 scales "physical functioning" (P = .004) and "role-physical" (P = .003). CONCLUSION EBRT for endometrial cancer is associated with long-term urinary and bowel symptoms and lower physical and role-physical functioning, even 15 years after treatment. Despite its efficacy in reducing locoregional recurrence, EBRT should be avoided in patients with low- and intermediate-risk EC.

[1]  P. Koper,et al.  Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial , 2000, The Lancet.

[2]  T. Whelan,et al.  Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis , 2009, The Lancet.

[3]  G. Samsioe,et al.  Quality of life in endometrial cancer survivors. , 1999, Maturitas.

[4]  P. Blake,et al.  Adjuvant external beam radiotherapy (EBRT) in the treatment of endometrial cancer: Results of the randomised MRC ASTEC and NCIC CTG EN.5 trial , 2007 .

[5]  Gunnar Steineck,et al.  Self-reported symptoms of faecal incontinence among long-term gynaecological cancer survivors and population-based controls. , 2010, European journal of cancer.

[6]  H. Putter,et al.  Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial , 2010, The Lancet.

[7]  P. Ganz,et al.  Refinement and psychometric evaluation of the impact of cancer scale. , 2008, Journal of the National Cancer Institute.

[8]  P. Koper,et al.  The morbidity of treatment for patients with stage I endometrial cancer: results from a randomized trial , 2002 .

[9]  D. Redelmeier,et al.  Interpreting clinically significant changes in patient‐reported outcomes , 2007, Cancer.

[10]  J. Roovers,et al.  Long-term cervical cancer survivors suffer from pelvic floor symptoms: a cross-sectional matched cohort study. , 2010, Gynecologic oncology.

[11]  V. Abeler,et al.  Postoperative External Irradiation and Prognostic Parameters in Stage I Endometrial Carcinoma: CLINICAL AND HISTOPATHOLOGIC STUDY OF 540 PATIENTS , 1980, Obstetrics and gynecology.

[12]  N. Aaronson,et al.  Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. , 1998, Journal of clinical epidemiology.

[13]  H. Geinitz,et al.  Late rectal symptoms and quality of life after conformal radiation therapy for prostate cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  Wendy Levinson,et al.  A study of sexuality and health among older adults in the United States. , 2007, The New England journal of medicine.

[15]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[16]  W. Bosch,et al.  Prevalence of urinary, fecal and double incontinence in the elderly living at home , 2004, International Urogynecology Journal.

[17]  P. Koper,et al.  Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. , 2000 .

[18]  U. Menon,et al.  Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24). , 2011, European journal of cancer.

[19]  Jan J W Lagendijk,et al.  Intrafraction motion in patients with cervical cancer: The benefit of soft tissue registration using MRI. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  V. Ramani,et al.  Chronic radiation enteritis. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

[21]  B. Anderson,et al.  Quality of life and mental health in cervical and endometrial cancer survivors. , 2006, Gynecologic oncology.

[22]  T. Le,et al.  Quality-of-life analysis in the management of endometrial cancer. , 2005, American journal of obstetrics and gynecology.

[23]  W. Small,et al.  Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. , 2008, International journal of radiation oncology, biology, physics.

[24]  P. Ganz,et al.  Assessing the impact of cancer: development of a new instrument for long‐term survivors , 2006, Psycho-oncology.

[25]  M. Hjermstad,et al.  Health-related quality of life and occurrence of intestinal side effects after pelvic radiotherapy--evaluation of long-term effects of diagnosis and treatment. , 2000, Acta oncologica.

[26]  R. Holloway,et al.  Disturbed colonic motility contributes to anorectal symptoms and dysfunction after radiotherapy for carcinoma of the prostate. , 2010, International journal of radiation oncology, biology, physics.

[27]  J. Coebergh,et al.  Impact of external beam adjuvant radiotherapy on health-related quality of life for long-term survivors of endometrial adenocarcinoma: a population-based study. , 2007, International journal of radiation oncology, biology, physics.

[28]  Marianne Klee, David Machin.  Health-related Quality of Life of Patients with Endometrial Cancer Who are Disease-free Following External Irradiation , 2001, Acta oncologica.

[29]  John C Roeske,et al.  Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. , 2003, International journal of radiation oncology, biology, physics.

[30]  A. Bottomley,et al.  An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. , 2003, European journal of cancer.

[31]  D. Tierney,et al.  Sexuality: a quality-of-life issue for cancer survivors. , 2008, Seminars in oncology nursing.

[32]  P. Koper,et al.  Survival after relapse in patients with endometrial cancer: results from a randomized trial. , 2003, Gynecologic oncology.

[33]  M Tubiana,et al.  The European Organization for Research and Treatment of Cancer (EORTC). , 1988, International journal of radiation oncology, biology, physics.

[34]  M. Maiman,et al.  A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. , 2004, Gynecologic oncology.

[35]  Hein Putter,et al.  Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  P. Koper,et al.  Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review. , 2005, International journal of radiation oncology, biology, physics.